The growth of Viagra and its effect on the drug landscape presents a complicated question for shareholders. While the initial sales data were remarkable, the exclusivity has ended, leading to a flood of off-brand https://kalelhxx827164.designi1.com/62096147/the-blue-pill-and-big-pharma-a-risky-opportunity